Upon completion of this activity, the participants should be able to:
- Identify appropriate clinical scenarios for the use of durvalumab as consolidation therapy following chemoradiation given with curative intent.
- Manage progression occurring during consolidation treatment with durvalumab.
- Choose the optical subsequent approach when progression occurs during consolidation treatment with durvalumab.